Gastroenterology

October 04, 2021

The administration of rapid intravenous fluid is the current practice for acute gastroenteritis, but does it actually lead to better outcomes?

September 22, 2021

A female aged 13 years with morbid obesity and recent hospitalization for pyelonephritis presents with abdominal pain, tachycardia, and shortness of breath. What's the diagnosis?

July 13, 2021

Gastrointestinal concerns are a common reason for a child's visit. This article offers a review of the most common ailments that may lead to that visit.

February 12, 2021

Often used to treat gastrointestinal concerns in children, proton pump inhibitors are thought to lead to respiratory concerns. A study examines this association.

December 03, 2020

When faced with a fussy infant, it's common to think acid reflux is the cause, but a recent report indicates that it may be time to think of other causes.

July 23, 2020

When diagnosing inflammatory bowel disease (IBD), pediatricians may want to avoid using endoscopy. Here’s a look at how 4 alternate strategies work.

June 08, 2020

Algorithms and evidence-based guidelines have become increasingly used for treating gastroenteritis, but can they lead to better outcomes?

February 17, 2020

Although the majority of patients with cystic fibrosis (CF) will be managed by specialty care, the primary care provider is often the first line of contact for many routine concerns. When encountering a patient with CF in the primary setting, there are extrapulmonary symptoms that must be considered in patients, which includes gastrointestinal symptoms.

February 13, 2020

Significant improvements in cystic fibrosis (CF) care have focused primarily on the pulmonary system, but addressing the gastrointestinal complications of CF presents a major opportunity for improvement in disease management.

February 01, 2019

 Of 973 preschool-aged children with acute gastroenteritis who visited 1 of 10 geographically diverse pediatric emergency departments (EDs), those who received a 5-day course of Lactobacillus rhamnosus GG, a commonly recommended and used probiotic, did not have better outcomes than those who received placebo, a prospective, randomized trial found.